CannaProtect IPM Solutions

Dosage is the key factor in achieving the most benefits and least adverse effects of cannabis. After following thousands of patients using medical cannabis for eight years, I’ve observed that dosing cannabis is unlike any therapeutic agent to which I was exposed in my medical training. A basic understanding of the key characteristics of cannabis dosing can empower you to make the most of this incredibly versatile, safe, and effective herb. The term therapeutic window descri...bes the range between the lowest effective dose and the dose that produces unwanted or intolerable side effects. People who have little or no experience using cannabis typically have a very narrow therapeutic window, while regular users develop a wider therapeutic window. This is due to the fact that individuals build tolerance to the various effects of cannabis at different rates, and most build tolerance to the unwanted effects faster than the desired effects. Most people are surprised to learn that the therapeutic effects of THC-dominant cannabis can be achieved at dosages lower than those required to produce euphoria or impairment. Cannabis microdosing, taking a non- or slightly psychoactive dose for the purpose of improving heath and productivity, has been gaining popularity. #WeProtectYourCannabis @CannaProtectIPM #WomenInBusiness #FemaleOwnedAndOperated #IPM #Science #Biofungicides #EnvironmentalMonitoring #PlantMedicine #HolisticHealth #PlantsOverPills #GoodVIBES #cannabis #weed #marijuana #cannabiseducation #cannabisresearch #cannabisheals #thc

Cannabis is a flower that has grown naturally in the wild for thousands of years. It’s chocked full of chemical constituentssome of which are known as cannabinoidsthat mesh with receptors throughout our body, eliciting a spectrum of mental and physical effects. THC or delta-9-tetrahydrocannabinol is by far the most well-known of these cannabinoids, but certainly isn’t the only powerful chemical compound native to the cannabis flower. Delta-8-THC, one of the four most common... cannabinoids, is similar to its psychoactive relative THC, but with several key differences. What Is Delta-8-THC? According to the National Cancer Institute, delta-8-THC can be defined as: An analogue of tetrahydrocannabinol (THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties. [Delta-8-THC] binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous systemThis agent exhibits a lower psychotropic potency than [delta-9-THC], the primary form of THC found in cannabis. The efficacy and stability of delta-8-THC make it an extremely valuable cannabis-derived chemical compound. The distillate’s benefits and effects serve both medical and recreational consumers alike, and it illustrates the power of individual chemical constituents within cannabis. As science defines and refines the applications for cannabis’s eclectic collection of cannabinoids, we will benefit, one puff at a time... #WeProtectYourCannabis @CannaProtectIPM #WomenInBusiness #FemaleOwnedAndOperated #IPM #Science #Biofungicides #EnvironmentalMonitoring #PlantMedicine #HolisticHealth #PlantsOverPills #GoodVIBES #cannabis #weed #marijuana #cannabiseducation #cannabisresearch #cannabisheals #thc

#WeProtectYourCannabis @CannaProtectIPM #WomenInBusiness #FemaleOwnedAndOperated #IPM... #Science #Biofungicides #EnvironmentalMonitoring #PlantMedicine #HolisticHealth #PlantsOverPills #GoodVIBES #cannabis #weed #marijuana #cannabiseducation #cannabisresearch #cannabisheals #thc See more

Could cannabis play a role in helping solve what could become a major public health crisis? The research so far is promising, but clearly we still need far more. As a society we need to make research a top priority it’s the compassionate and fiscally responsible thing to do. Inevitably, the DEA will remove barriers to conducting the type of rigorous research scientists want (and need) to do, and soon we should have better answers to some important questions: * Can cannabis ...or specific cannabinoids boost the endocannabinoid system (ECS) enough to slow down, halt, or reverse the progression of any of the neurodegenerative diseases? * Can the neuroprotective or anti-inflammatory effects of cannabis or specific cannabinoids prevent onset of neurodegenerative disease or significantly decrease our risk for acquiring a disease? As anyone who has had a family member with a neurodegenerative disease knows, watching a loved one’s health deteriorate before your very eyes can be one of the most painful experiences you’ll ever go through. We can hope that we continue making advancements in understanding not just the potential role of cannabis, but of the root causes of these diseases. Perhaps then we can alleviate the suffering that millions of families across the world experience. #WeProtectYourCannabis @CannaProtectIPM #WomenInBusiness #FemaleOwnedAndOperated #IPM #Science #Biofungicides #EnvironmentalMonitoring #PlantMedicine #HolisticHealth #PlantsOverPills #GoodVIBES #cannabis #weed #marijuana #cannabiseducation #cannabisresearch #cannabisheals #thc https://www.leafly.ca//how-does-cannabis-consumption-affec

Improving our understanding of the endocannabinoid system... The endocannabinoid system wasn’t discovered until the 1990s, making it a relatively new system where much is still unknown. The two receptors in the endocannabinoid system, CB1 and CB2, look similar but function quite differently. As a result, it’s been difficult to find drugs that selectively activate one over the other. The holy grail of a cannabinoid-based drug would be one designed to treat neurodegenerative di...sorders and pain, and to also provide neuroprotection, by selectively activating CB2 receptors without activating CB1 receptors, enabling the benefits of dampening inflammation without causing a high. To do so, drug designers need to know what both these receptors look like when resting and when activated. The problem: They’re really small. CB1 and CB2 receptors also play a competing role in cannabis’ rewarding effects. According to a study published at the tail-end of 2020, CB1 receptors are responsible for the pleasurable nature of low amounts of THC, but the effects of high doses become aversive due to the activation of CB2 receptors. Activating these CB2 receptors reduces the amount of dopamine, a brain chemical that codes information regarding what was good so that you can seek it out again. This counteracts the dopamine-boosting effects of activating CB1 receptors. Some of us consume cannabis for its mind-altering effects, while others seek symptom relief. But cannabis wouldn’t get us high or have some of its therapeutic benefits if our bodies didn’t already contain a biological system capable of interacting with its active chemical compounds, like THC. #WeProtectYourCannabis @CannaProtectIPM #WomenInBusiness #FemaleOwnedAndOperated #IPM #Science #Biofungicides #EnvironmentalMonitoring #PlantMedicine #HolisticHealth #PlantsOverPills #GoodVIBES #cannabis #weed #marijuana #cannabiseducation #cannabisresearch #cannabisheals #thc